Bioident opens U.S. office, launches PhotonicsLab
MENLO PARK, CA-Bioident Technologies, a subsidiary of Nanoident Technologies (Linz, Austria) that is developing photonic lab-on-a-chip solutions for life sciences, has opened headquarters in Menlo Park, CA.
MENLO PARK, CA-Bioident Technologies, a subsidiary of Nanoident Technologies (Linz, Austria) that is developing photonic lab-on-a-chip solutions for life sciences, has opened headquarters in Menlo Park, CA. In addition, Bioident has appointed two executives with expertise in nanotechnology, printed organic semiconductors, and biophotonics to Bioident: Wasiq Bokhari, CEO and Max Sonnleitner, CTO.
Bioident is leveraging printed optoelectronics and microfluidics to create a new class of photonic lab-on-a-chip systems that are designed to enable real-time, multiparameter detection and analysis capabilities for mobile field, diagnostic, and point-of-care applications. According to the company, these lab-on-a-chip systems will be used for mobile water and food analysis, chemical, and biological agent detection and in-vitro diagnostics-markets the company says represent a $7.5 billion addressable opportunity.
“Bioident technology represents the ideal marriage of printed organic optoelectronic components and microfluidics, which will dramatically transform mobile diagnostic and in-field analysis applications,” Bokhari said. “For companies that provide analysis and diagnostic systems, Bioident’s technology platform can address multiple applications, saving time and money for manufacturers and end customers.”
The Biodent Platform uses organic semiconductor-based technology to print light-emitting and detecting capabilities directly onto any surface, including polymers and glass, enabling on-chip detection and analysis capabilities. This platform eliminates the need for external, expensive, bulky readout systems, enabling mobile analytics and diagnostics, immediate test results, and cost savings. The chips will also analyze multiple test parameters with a single chip in real time, substantially increasing testing efficiencies.
“The PhotonicLab Platform is poised to revolutionize water and food analysis, chemical and biological agent detection, and in-vitro diagnostics,” Bokhari said. “Imagine: instead of waiting for days for water or blood test results from a lab, with Bioident technology we can have multiparameter results immediately, at the point of use.”